Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma

Michelle L. Varney, Sonny L. Johansson, Rakesh K Singh

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

We examined the expression of CXCL8 (interleukin-8), its receptors, CXCR1 and CXCR2, and vessel density in human melanoma by immunohistochemical analysis of tumors from different Clark levels, depths, and thicknesses. Expression of CXCL8 and CXCR2 was lower in Clark level I and II specimens than in level III through V specimens and metastases. CXCR1 expression was observed ubiquitously in the majority of human melanoma tumor specimens irrespective of disease state, with the highest intensity in Clark level III specimens. We observed a significant difference in CXCL8 and CXCR2 expression between thin (≤0.75 mm) and thick (>0.75 mm) melanomas and between thin and metastatic lesions. Positive correlations were observed between Clark level and CXCL8 or CXCR2 and between thickness and CXCR2 expression. We found no correlation between vessel density and Clark level or thickness. Our data suggest that expression of CXCL8 and CXCR2 contributes to aggressive growth and metastasis in human malignant melanoma. Consistent with the transition from radial to vertical growth phase melanoma, expression of CXCL8 and its receptor, CXCR2, may be key in the switch to an aggressive, more metastatic phenotype.

Original languageEnglish (US)
Pages (from-to)209-216
Number of pages8
JournalAmerican journal of clinical pathology
Volume125
Issue number2
DOIs
StatePublished - Jan 1 2006

Fingerprint

Interleukin-8A Receptors
Interleukin-8B Receptors
Melanoma
Interleukin-8 Receptors
Neoplasm Metastasis
Growth
Neoplasms
Phenotype

Keywords

  • Angiogenesis
  • CXCR1
  • CXCR2
  • Interleukin-8/CXCL8
  • Metastasis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. / Varney, Michelle L.; Johansson, Sonny L.; Singh, Rakesh K.

In: American journal of clinical pathology, Vol. 125, No. 2, 01.01.2006, p. 209-216.

Research output: Contribution to journalArticle

@article{96eddfad16f748b8bd886d7de8d8f2c5,
title = "Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma",
abstract = "We examined the expression of CXCL8 (interleukin-8), its receptors, CXCR1 and CXCR2, and vessel density in human melanoma by immunohistochemical analysis of tumors from different Clark levels, depths, and thicknesses. Expression of CXCL8 and CXCR2 was lower in Clark level I and II specimens than in level III through V specimens and metastases. CXCR1 expression was observed ubiquitously in the majority of human melanoma tumor specimens irrespective of disease state, with the highest intensity in Clark level III specimens. We observed a significant difference in CXCL8 and CXCR2 expression between thin (≤0.75 mm) and thick (>0.75 mm) melanomas and between thin and metastatic lesions. Positive correlations were observed between Clark level and CXCL8 or CXCR2 and between thickness and CXCR2 expression. We found no correlation between vessel density and Clark level or thickness. Our data suggest that expression of CXCL8 and CXCR2 contributes to aggressive growth and metastasis in human malignant melanoma. Consistent with the transition from radial to vertical growth phase melanoma, expression of CXCL8 and its receptor, CXCR2, may be key in the switch to an aggressive, more metastatic phenotype.",
keywords = "Angiogenesis, CXCR1, CXCR2, Interleukin-8/CXCL8, Metastasis",
author = "Varney, {Michelle L.} and Johansson, {Sonny L.} and Singh, {Rakesh K}",
year = "2006",
month = "1",
day = "1",
doi = "10.1309/VPL5R3JR7F1D6V03",
language = "English (US)",
volume = "125",
pages = "209--216",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "2",

}

TY - JOUR

T1 - Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma

AU - Varney, Michelle L.

AU - Johansson, Sonny L.

AU - Singh, Rakesh K

PY - 2006/1/1

Y1 - 2006/1/1

N2 - We examined the expression of CXCL8 (interleukin-8), its receptors, CXCR1 and CXCR2, and vessel density in human melanoma by immunohistochemical analysis of tumors from different Clark levels, depths, and thicknesses. Expression of CXCL8 and CXCR2 was lower in Clark level I and II specimens than in level III through V specimens and metastases. CXCR1 expression was observed ubiquitously in the majority of human melanoma tumor specimens irrespective of disease state, with the highest intensity in Clark level III specimens. We observed a significant difference in CXCL8 and CXCR2 expression between thin (≤0.75 mm) and thick (>0.75 mm) melanomas and between thin and metastatic lesions. Positive correlations were observed between Clark level and CXCL8 or CXCR2 and between thickness and CXCR2 expression. We found no correlation between vessel density and Clark level or thickness. Our data suggest that expression of CXCL8 and CXCR2 contributes to aggressive growth and metastasis in human malignant melanoma. Consistent with the transition from radial to vertical growth phase melanoma, expression of CXCL8 and its receptor, CXCR2, may be key in the switch to an aggressive, more metastatic phenotype.

AB - We examined the expression of CXCL8 (interleukin-8), its receptors, CXCR1 and CXCR2, and vessel density in human melanoma by immunohistochemical analysis of tumors from different Clark levels, depths, and thicknesses. Expression of CXCL8 and CXCR2 was lower in Clark level I and II specimens than in level III through V specimens and metastases. CXCR1 expression was observed ubiquitously in the majority of human melanoma tumor specimens irrespective of disease state, with the highest intensity in Clark level III specimens. We observed a significant difference in CXCL8 and CXCR2 expression between thin (≤0.75 mm) and thick (>0.75 mm) melanomas and between thin and metastatic lesions. Positive correlations were observed between Clark level and CXCL8 or CXCR2 and between thickness and CXCR2 expression. We found no correlation between vessel density and Clark level or thickness. Our data suggest that expression of CXCL8 and CXCR2 contributes to aggressive growth and metastasis in human malignant melanoma. Consistent with the transition from radial to vertical growth phase melanoma, expression of CXCL8 and its receptor, CXCR2, may be key in the switch to an aggressive, more metastatic phenotype.

KW - Angiogenesis

KW - CXCR1

KW - CXCR2

KW - Interleukin-8/CXCL8

KW - Metastasis

UR - http://www.scopus.com/inward/record.url?scp=31544456603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31544456603&partnerID=8YFLogxK

U2 - 10.1309/VPL5R3JR7F1D6V03

DO - 10.1309/VPL5R3JR7F1D6V03

M3 - Article

VL - 125

SP - 209

EP - 216

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 2

ER -